+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Radiotherapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • PDF Icon

    Report

  • 183 Pages
  • May 2025
  • Region: Global
  • TechSci Research
  • ID: 5895988
Free Webex Call
10% Free customization
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The Radiotherapy Market was valued at USD 6.54 Billion in 2024, and is expected to reach USD 10.68 Billion by 2030, rising at a CAGR of 8.52%. Radiotherapy remains a cornerstone in cancer treatment, employing ionizing radiation to eliminate or shrink cancer cells and manage disease progression. With the increasing global incidence of cancer and the rising focus on non-invasive therapeutic solutions, radiotherapy is witnessing robust growth. The adoption of advanced technologies like IMRT, SBRT, and proton therapy is transforming the treatment landscape, offering higher precision and fewer side effects. Additionally, the integration of AI, real-time imaging, and radiosurgery techniques is enhancing treatment outcomes and operational efficiency. The global healthcare ecosystem’s emphasis on effective oncology care, coupled with the growing demand for personalized and targeted treatments, continues to drive the expansion of the radiotherapy market.

Key Market Drivers

Technological Advancements

Ongoing technological innovations have significantly fueled the growth of the Global Radiotherapy Market. The emergence of advanced techniques like Intensity-Modulated Radiation Therapy (IMRT), Stereotactic Body Radiation Therapy (SBRT), and Proton Therapy has revolutionized cancer care by enabling highly accurate targeting of tumors while preserving surrounding healthy tissue.

This precision leads to improved outcomes and fewer adverse effects, making radiotherapy a preferred choice. Artificial Intelligence (AI) and Machine Learning (ML) are increasingly integrated into treatment planning, enhancing dose optimization and patient response prediction. Image-Guided Radiotherapy (IGRT) further ensures real-time monitoring during treatment, improving targeting accuracy. Additionally, the development of Radiosurgery and Stereotactic Radiosurgery (SRS) allows for high-dose, single-session treatments for small tumors, offering patients convenience and reduced treatment durations.

Key Market Challenges

Cost and Accessibility Barriers

One of the major barriers in the radiotherapy market is the high cost of implementation. Advanced radiotherapy systems, such as linear accelerators and proton therapy units, demand substantial capital investment, which can be a major hurdle for healthcare providers, especially in under-resourced regions. Beyond the purchase, ongoing maintenance, staff training, and operational expenses place additional financial pressure on facilities. Disparities in access are also a concern, with rural and low-income areas often lacking sufficient infrastructure for radiotherapy services. These challenges contribute to unequal access to advanced cancer care, limiting the market's reach and slowing the pace of widespread adoption despite growing demand.

Key Market Trends

Advanced Radiation Delivery Techniques

The evolution of advanced radiation delivery methods is reshaping the radiotherapy landscape. Techniques such as IMRT allow for modulation of radiation intensity to different areas of the tumor, minimizing impact on nearby healthy tissues and improving treatment precision. Proton therapy offers an even more targeted approach, as protons release energy directly at the tumor site, reducing collateral damage. Additionally, hypofractionation - delivering higher doses over fewer sessions - is gaining popularity for its convenience and efficiency. Stereotactic Radiosurgery (SRS), a form of hypofractionation, is increasingly used for treating small brain and body tumors. These innovations align with the growing demand for personalized treatment strategies that prioritize both efficacy and patient quality of life.

Key Market Players

  • Canon Medical Systems Corporation
  • GE Healthcare
  • Elekta
  • ViewRay Technologies, Inc.
  • Mevion Medical Systems
  • Eckert & Ziegler (BEBIG Medical)
  • Siemens Healthineers AG
  • Accuray Incorporated
  • Isoray Inc.
  • Hitachi, Ltd.
  • ALCEN (PMB)

Report Scope:

In this report, the Global Radiotherapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Radiotherapy Market, By Type:

  • External Beam Radiation Therapy
  • Internal Radiation Therapy
  • Systemic Radiation Therapy

Radiotherapy Market, By Application:

  • Skin & Lip Cancer
  • Breast Cancer
  • Prostate Cancer
  • Cervical Cancer
  • Lung Cancer
  • Others

Radiotherapy Market, By End-User:

  • Hospitals
  • Research Institutes
  • Ambulatory and Radiotherapy Centers

Radiotherapy Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Radiotherapy Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Radiotherapy Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (External Beam Radiation Therapy, Internal Radiation Therapy, Systemic Radiation Therapy)
5.2.2. By Application (Skin & Lip Cancer, Breast Cancer, Prostate Cancer, Cervical Cancer, Lung Cancer, Others)
5.2.3. By End-User (Hospitals, Research Institutes, Ambulatory and Radiotherapy Centers)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map
6. North America Radiotherapy Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Application
6.2.3. By End-User
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Radiotherapy Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Application
6.3.1.2.3. By End-User
6.3.2. Canada Radiotherapy Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Application
6.3.2.2.3. By End-User
6.3.3. Mexico Radiotherapy Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Application
6.3.3.2.3. By End-User
7. Europe Radiotherapy Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Application
7.2.3. By End-User
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Radiotherapy Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Application
7.3.1.2.3. By End-User
7.3.2. United Kingdom Radiotherapy Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Application
7.3.2.2.3. By End-User
7.3.3. Italy Radiotherapy Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Application
7.3.3.2.3. By End-User
7.3.4. France Radiotherapy Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Application
7.3.4.2.3. By End-User
7.3.5. Spain Radiotherapy Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Application
7.3.5.2.3. By End-User
8. Asia-Pacific Radiotherapy Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Application
8.2.3. By End-User
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Radiotherapy Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Application
8.3.1.2.3. By End-User
8.3.2. India Radiotherapy Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Application
8.3.2.2.3. By End-User
8.3.3. Japan Radiotherapy Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Application
8.3.3.2.3. By End-User
8.3.4. South Korea Radiotherapy Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Application
8.3.4.2.3. By End-User
8.3.5. Australia Radiotherapy Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Application
8.3.5.2.3. By End-User
9. South America Radiotherapy Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Application
9.2.3. By End-User
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Radiotherapy Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Application
9.3.1.2.3. By End-User
9.3.2. Argentina Radiotherapy Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Application
9.3.2.2.3. By End-User
9.3.3. Colombia Radiotherapy Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Application
9.3.3.2.3. By End-User
10. Middle East and Africa Radiotherapy Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Application
10.2.3. By End-User
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Radiotherapy Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Application
10.3.1.2.3. By End-User
10.3.2. Saudi Arabia Radiotherapy Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Application
10.3.2.2.3. By End-User
10.3.3. UAE Radiotherapy Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Application
10.3.3.2.3. By End-User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions
13. Global Radiotherapy Market: SWOT Analysis
14. Competitive Landscape
14.1. Canon Medical Systems Corporation
14.1.1. Business Overview
14.1.2. Company Snapshot
14.1.3. Products & Services
14.1.4. Financials (As Reported)
14.1.5. Recent Developments
14.1.6. Key Personnel Details
14.1.7. SWOT Analysis
14.2. GE Healthcare
14.3. Elekta
14.4. ViewRay Technologies, Inc.
14.5. Mevion Medical Systems
14.6. Eckert & Ziegler (BEBIG Medical)
14.7. Siemens Healthineers AG
14.8. Accuray Incorporated
14.9. Isoray Inc.
14.10. Hitachi, Ltd.
14.11. ALCEN (PMB)
15. Strategic Recommendations16. About the Publisher & Disclaimer

Companies Mentioned

  • Canon Medical Systems Corporation
  • GE Healthcare
  • Elekta
  • ViewRay Technologies, Inc.
  • Mevion Medical Systems
  • Eckert & Ziegler (BEBIG Medical)
  • Siemens Healthineers AG
  • Accuray Incorporated
  • Isoray Inc.
  • Hitachi, Ltd.
  • ALCEN (PMB)

Table Information